Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
University of Leicester · University Hospitals of Leicester NHS Trust · +23 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
970
total citations
- FWCI
- 114.70
- Percentile
- 100%
- References
- 353
Citations per year
Authors
14- MJMelanie J. DaviesCorresponding
University of Leicester, University Hospitals of Leicester NHS Trust, NIHR Leicester Biomedical Research Centre
- VRVanita R. Aroda
Brigham and Women's Hospital, Harvard University
- BSBilly S. Collins
National Heart Lung and Blood Institute
- RARobert A. Gabbay
Ada Technologies (United States)
- JGJennifer Green
Duke University, Clinical Research Institute
Topics & keywords
Topics
Keywords
- Diabetes mellitus
- Medicine
- Type 2 diabetes
- Human physiology
- Association (psychology)
- Internal medicine
- Endocrinology
- Psychology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- ADAmerican Diabetes Association
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- GSGilead Sciences
- OSOhio State University
- MMedpace
- JHJohns Hopkins University
- UHUniversity Hospitals of Leicester NHS Trust
- ICInsulet Corporation
- RMReCor Medical
- DDexcom
- MModerna
- UOUniversity of Leicester
- UOUniversity of Southampton
- NUNewcastle University
- EFEuropean Foundation for the Study of Diabetes
- DSDaewoo Shipbuilding & Marine Engineering
- KLKU Leuven
- NNNovo Nordisk
- SUSapienza Università di Roma
- APAstellas Pharma
- UDUniversitat de Barcelona
- AUAristotle University of Thessaloniki
- EAEuropean Association for the Study of Diabetes
- SServier
- UOUniversity of North Carolina at Chapel Hill
- TPTakeda Pharmaceuticals International